Role of imprinting in abnormal human development

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 396, Issue 1-2, 1997, Pages 141-147

  Mutter, George L ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Imprinting; Molecular genetics; Teratology

Indexed keywords

CARCINOGENESIS; GENE EXPRESSION; GENE MUTATION; GENOME IMPRINTING; HUMAN; MALFORMATION SYNDROME; NONHUMAN; OVARY TERATOMA; PARTHENOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; UNIPARENTAL DISOMY;

EID: 0031565929     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00180-2     Document Type: Article

References (74)

1. Barton S., Surani M., Norris M. Role of paternal and maternal genomes in mouse development. Nature. 311:1984;374-376.
2. Moore T., Haig D. Genomic imprinting in mammalian development: A parental tug-of-war. Trends Genet. 7:1991;45-49.
3. Bestor T. Methylation patterns in the vertebrate genome. J. NIH Res. 5:1993;57-60.
4. Bird A. The essentials of DNA methylation. Cell. 70:1992;5-8.
5. DeChiara T., Robertson E., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 64:1991;849-859.
6. Ohlsson R., Nystrom A., Pfeifer-Ohlsson S., Tohonen V., Hedborg F., Schofield P., Flam F., Ekstrom T. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedmann syndrome. Nature Genet. 4:1993;94-97.
7. Barlow D., Stoger R., Herrmann B., Saito K., Schweifer N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature. 349:1991;84-87.
8. Bartolomei M., Zemel S., Tilghman S. Parental imprinting of the mouse H19 gene. Nature. 351:1991;153-155.
9. Brannan C., Dees E., Ingram R., Tilghman S. The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10:1990;28-36.
10. Zhang Y., Tycko B. Monoallelic expression of the human H19 gene. Nature Genet. 1:1992;40-44.
11. Ferguson-Smith A.C., Sasaki H., Cattanach B.M., Surani M.A. Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature. 362:1993;751-755.
12. Zhang Y., Shields T., Crenshaw T., Hao Y., Moulton T., Tycko B. Imprinting of human H19: Allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am. J. Hum. Genet. 53:1993;113-124.
13. Reed M.L., Leff S.E. Maternal imprinting of human SNRPN, a gene deleted in Prader-Willi syndrome. Nature Genet. 6:1994;163-167.
14. Glenn C.C., Porter K.A., Jong M.T.C., Nicholls R.D., Driscoll D.J. Functional imprinting and epigenetic modification of the human SNRPN gene. Hum. Mol. Genet. 2:1993;2001-2005.
15. Leff S., Brannan C., Reed M., Ozcelik T., Francke U., Copeland N., Jenkins N. Maternal imprinting of the mouse Snrpn gene and conserved linkage homology with the human Prader-Willi syndrome region. Nature Genet. 2:1992;259-264.
16. Villar A.J., Pedersen R.A. Parental imprinting of the Mas protooncogene in mouse. Nature Genet. 8:1994;373-379.
17. Jinno Y., Yun K., Nishiwaki K., Kubota T., Ogawa O., Reeve A.E., Niikawa N. Mosaic and polymorphic imprinting of the WT1 gene in humans. Nature Genet. 6:1994;305-309.
18. Guillemot F., Caspary T., Tilghman S., Copeland N., Gilbert D., Jenkins N., Anderson D., Joyner A., Rossant J., Nagy A. Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nature Genet. 9:1995;235-242.
19. Brunkow M., Tilghman S. Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Dev. 5:1991;1092-1101.
20. Zemel S., Bartolomei M., Tilghman S. Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nature Genet. 2:1992;61-65.
21. Surani M.A., Barton S.C., Norris M.L. Influence of parental chromosomes on spatial specificity in androgenetic- parthenogenetic chiameras in the mouse. Nature. 326:1987;395-397.
22. Mutter G.L. Teratoma genetics and stem cells: a review. Obstet. Gynecol. Surv. 42:1987;661-670.
23. R. Scully, Tumors of the Ovary and Maldeveloped Gonads, Armed Forces Institute of Pathology, Washington, DC, 1979, pp. 226-286.
24. Eppig J.J., Kozak L.P., Eicher E.M., Stevens L.C. Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division. Nature. 269:1977;517-518.
25. Parrington J., West L., Povey S. Gene mapping from ovarian teratomas. Cytogenet. Cell Genet. 25:1979;196.
26. Surti U., Hoffner L., Chakravarti A., Ferrell R.E. Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin Am. J. Hum. Genet. 47:1990;635-643.
27. Stevens L.C., Varnum D.S. The development of teratomas from parthenogenetically activated ovarian mouse eggs. Dev. Biol. 37:1974;369-380.
28. Illmense K., Mintz B. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc. Natl. Acad. Sci. USA. 73:1976;549-553.
29. Martin G. Teratocarcinomas and mammalian embryogenesis. Science. 209:1980;768-776.
30. Grimes D.A. Epidemiology of gestational trophoblastic disease. Am. J. Obstet. Gynecol. 150:1984;309-318.
31. Kajii T., Ohama K. Androgenetic origin of hydatidiform mole. Nature. 268:1977;633-634.
32. Lawler S.D., Povey S., Fisher R.A., Pickthall V.J. Genetic studies on hydatidiform moles. II. The origin of complete moles Ann. Hum. Genet. 46:1982;209-222.
33. Azuma C., Saji F., Tokugawa Y., Kimura T., Nobunaga T., Takemura M., Kameda T., Tanizawa O. Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole. Gynecol. Oncol. 40:1991;29-33.
34. Wallace D.C., Surti U., Adams C.W., Szulman A.E. Complete moles have paternal chromosomes but maternal mitochondrial DNA. Hum. Genet. 61:1982;145-147.
35. Lawler S., Fisher R., Dent J. A prospective genetic study of complete and partial hydatidiform moles. Am. J. Obstet. Gynecol. 164:1991;1270-1277.
36. Ohama K., Kajii T., Okamoto E., Fukuda Y., Imaizumi K., Tsukahara M., Kobayashi K., Hagiwara K. Dispermic origin of XY hydatidiform moles. Nature. 292:1981;551-552.
37. Fisher R.A., Povey S., Jeffreys A.J., Martin C.A., Patel I., Lawler S.D. Frequency of heterozygous complete hydatidiform moles, estimated by locus-specific minisatellite and Y chromosome-specific probes. Hum. Genet. 82:1989;259-263.
38. Henry I., Bonaiti-Pellie C., Chehensse V., Beldjord C., Schwartz C., Utermann G., Junien C. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature. 351:1991;665-667.
39. Little M., Van Heyningen V., Hastie N. Dads and disomy and disease. Nature. 351:1991;609-610.
40. Lage J.M. Placentomegaly with massive hydrops of placental stem villi, diploid DNA content and fetal omphaloceles: Possible association with Beckwith-Wiedemann syndrome. Hum. Pathol. 22:1991;591-597.
41. Weksberg R., Squire J.A. Molecular biology of Beckwith-Wiedemann syndrome. Med. Pediatr. Oncol. 27:1996;462-469.
42. Cohen M.M. Jr. Wiedemann-Beckwith syndrome, imprinting, IGF2, and H19: Implications for hemihyperplasia, associated neoplasms, and overgrowth. Am. J. Med. Genet. 52:1994;233-234.
43. Reik W., Brown K.W., Slatter R.E., Sartori P., Elliott M., Maher E.R. Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann syndrome. Hum. Mol. Genet. 3:1994;1297-1301.
44. Weksberg R., Shen D.R., Fei Y.L., Song Q.L., Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet. 5:1993;143-150.
45. Feinberg R.F., Lockwood C.J., Salafia C., Hobbins J.C. Sonographic diagnosis of a pregnancy with a diffuse hydatidiform mole and coexistent 46, XX fetus: A case report. Obstet. Gynecol. 72:1988;485-488.
46. Lindor N.M., Karnes P.S., Michels V.V., Dewald G.W., Goerss J., Jalal S., Jenkins R.B., Vockley G., Thibodeau S.N. Uniparental disomy in congenital disorders: a prospective study. Am. J. Med. Genet. 58:1995;143-146.
47. Ledbetter D.H., Engel E. Uniparental disomy in humans: development of an imprinting map and its implications for prenatal diagnosis. Hum. Mol. Genet. 4:1995;1757-1764.
48. Donnai D. Robertsonian translocations: Clues to imprinting. Am. J. Med. Genet. 46:1993;681-682.
49. Kalousek D.K. Current topic: confined placental mosaicism and intrauterine fetal development. Placenta. 15:1994;219-230.
50. Kalousek D.K., Barrett I. Confined placental mosaicism and stillbirth. Pediatr. Pathol. 14:1994;151-159.
51. Robinson W., Binkert F., Bernasconi F., Lorda-Sanchez I., Werder E., Schinzel A. Molecular studies of chromosomal mosaicism: relative frequency of chromosome gain or loss and possible role of cell selection. Am. J. Hum. Genet. 56:1995;444-451.
52. Wolstenholme J. Confined placental mosaicism for trisomies 2, 3, 7, 8, 9, 16, and 22: their incidence, likely origins, and mechanisms for cell lineage compartmentalization. Prenat. Diagn. 16:1996;511-524.
53. Kalousek D.K., Howard-Peebles P.N., Olson S.B., Barrett I.J., Dorfmann A., Black S.H., Schulman J.D., Wilson R.D. Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism. Prenat. Diagn. 11:1991;743-750.
54. Kalousek D.K., Barrett I.J., Gartner A.B. Spontaneous abortion and confined chromosomal mosaicism. Hum. Genet. 88:1992;642-646.
55. Kalousek D., Langlois S., Barrett I., Yam I., Wilson D., Howard-Peebles P., Johnson M., Giorgiutti E. Uniparental disomy for chromosome 16 in humans. Am. J. Hum. Genet. 52:1993;8-16.
56. Nicholls R.D. Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: A review. Am. J. Med. Genet. 46:1993;16-25.
57. Driscoll D., Waters M., Williams C., Zori R., Glenn C., Avidano K., Nicholls R. A DNA methylation imprint, determined by the sex of the parent, distinguishes the Angelman and Prader-Willi syndromes. Genomics. 13:1992;917-924.
58. Mascari M., Gottleib W., Rogan P., Butler M., Waller D., Armour J., Jeffreys M., Ladda R., Nicholls R. The frequency of uniparental disomy in Prader-Willi syndrome. N. Engl. J. Med. 326:1992;1599-1607.
59. Nicholls R., Rinchik E., Driscoll D. Genomic imprinting in mammalian development: Prader-Willi and Angelman syndromes as disease models. Dev. Biol. 3:1992;139-152.
60. K.L. Jones, Smith's Recognizable Patterns of Human Malformation, W.B. Saunders, Philadelphia, 1988.
61. Knoll J.H.M., Cheng S.-D., Lalande M. Allele specificity of DNA replication timing in the Angelman/Prader-Willi syndrome imprinted chromosomal region. Nature Genet. 6:1994;41-46.
62. Glenn C.C., Nicholls R.D., Robinson W.P., Saitoh S., Niikawa N., Schinzel A., Horsthemke B., Driscoll D.J. Modification of 15q11-q13 DNA methylation imprints in unique Angelman and Prader-Willi patients. Hum. Mol. Genet. 2:1993;1377-1382.
63. Ozcelik T., Leff S., Robinson W., Donlon T., Lalande M., Sanjines E., Schinzel A., Francke U. Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region. Nature Genet. 2:1992;265.
64. Nakao M., Sutcliffe J.S., Durtschi B., Mutirangura A., Ledbetter D.H., Beaudet A.L. Imprinting analysis of three genes in the Prader-Willi/Angelman region: SNRPN, E6-associated protein, and PAR-2 (D15S225E). Hum. Mol. Genet. 3:1994;309-315.
65. Woodage T., Deng Z.M., Prasad M., Smart R., Lindeman R., Christian S.L., Ledbetter D.H., Robson L., Smith A., Trent R.J. A variety of genetic mechanisms are associated with the Prader-Willi syndrome. Am. J. Med. Genet. 54:1994;219-226.
66. Toth-Fejel S., Olson S., Gunter K., Quan F., Wolford J., Popovich B.W., Magenis R.E. The impact of imprinting: Prader-Willi syndrome resulting from chromosome translocation, recombination, and nondisjunction. Am. J. Hum. Genet. 58:1996;1008-1016.
67. Ogawa O., Eccles M.R., Szeto J., McNoe L.A., Yun K., Maw M.A., Smith P.J., Reeve A.E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 362:1993;749-751.
68. Rainier S., Johnson L., Dobry C., Ping A., Grundy P., Feinberg A. Relaxation of imprinted genes in human cancer. Nature. 362:1993;747-749.
69. Hashimoto K., Azuma C., Koyama M., Ohashi K., Kamiura S., Nobunaga T., Kimura T., Tokugawa Y., Kanai T., Saji F. Loss of imprinting in choriocarcinoma. Nature Genet. 9:1995;109-110.
70. Vu T.H., Yballe C., Boonyanit S., Hoffman A.R. Insulin-like growth factor II in uterine smooth-muscle tumors: Maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J. Clin. Endocrinol. Metab. 80:1995;1670-1676.
71. Mutter G.L., Pomponio R., Berkowitz R., Genest D. Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. Am. J. Obstet. Gynecol. 168:1993;1547-1551.
72. Mutter G.L., Stewart C.L., Chaponot M.L., Pomponio R.J. Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast. Am. J. Hum. Genet. 53:1993;1096-1102.
73. Walsh C., Miller S.J., Flam F., Fisher R.A., Ohlsson R. Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast. Cancer Res. 55:1995;1111-1116.
74. G.L. Mutter, Gestational trophoblastic disease, in: S.P. Langdon, W.R. Miller, A. Berchuck, Biology of Female Cancers, CRC, Boca Raton, FL, 1997, pp. 271-281.